CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL

H Guhring; J Kraines; F Moreau; B Daelken; C Ladel; Wolfgang Wirth; PG Conaghan; Felix Eckstein; M Hochberg

doi:10.1136/annrheumdis-2019-eular.1216

CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL

H Guhring, J Kraines, F Moreau, B Daelken, C Ladel, Wolfgang Wirth, PG Conaghan, Felix Eckstein, M Hochberg

Institute of Anatomy and Cell Biology Salzburg

Research output: Contribution to journal › Abstract (Journal) › peer-review

10 Citations (Web of Science)

Original language	English
Pages (from-to)	70-71
Journal	ANNALS OF THE RHEUMATIC DISEASES
Volume	78
DOIs	https://doi.org/10.1136/annrheumdis-2019-eular.1216
Publication status	Published - 2019
Event	Annual European Congress of Rheumatology (EULAR) - Madrid, SPAIN Duration: 12 Jun 2019 → 15 Jun 2019

Access to Document

10.1136/annrheumdis-2019-eular.1216

Cite this

Guhring, H., Kraines, J., Moreau, F., Daelken, B., Ladel, C., Wirth, W., Conaghan, PG., Eckstein, F., & Hochberg, M. (2019). CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL. ANNALS OF THE RHEUMATIC DISEASES, 78, 70-71. https://doi.org/10.1136/annrheumdis-2019-eular.1216

@article{9149100a0c42436a92bac9fe16eb6eb5,

title = "CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL",

author = "H Guhring and J Kraines and F Moreau and B Daelken and C Ladel and Wolfgang Wirth and PG Conaghan and Felix Eckstein and M Hochberg",

year = "2019",

doi = "10.1136/annrheumdis-2019-eular.1216",

language = "English",

volume = "78",

pages = "70--71",

journal = "ANNALS OF THE RHEUMATIC DISEASES",

issn = "0003-4967",

publisher = "BMJ ",

note = "Annual European Congress of Rheumatology (EULAR) ; Conference date: 12-06-2019 Through 15-06-2019",

}

Guhring, H, Kraines, J, Moreau, F, Daelken, B, Ladel, C, Wirth, W, Conaghan, PG, Eckstein, F & Hochberg, M 2019, 'CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL', ANNALS OF THE RHEUMATIC DISEASES, vol. 78, pp. 70-71. https://doi.org/10.1136/annrheumdis-2019-eular.1216

CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL. / Guhring, H; Kraines, J; Moreau, F et al.
In: ANNALS OF THE RHEUMATIC DISEASES, Vol. 78, 2019, p. 70-71.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL

AU - Guhring, H

AU - Kraines, J

AU - Moreau, F

AU - Daelken, B

AU - Ladel, C

AU - Wirth, Wolfgang

AU - Conaghan, PG

AU - Eckstein, Felix

AU - Hochberg, M

PY - 2019

Y1 - 2019

U2 - 10.1136/annrheumdis-2019-eular.1216

DO - 10.1136/annrheumdis-2019-eular.1216

M3 - Abstract (Journal)

SN - 0003-4967

VL - 78

SP - 70

EP - 71

JO - ANNALS OF THE RHEUMATIC DISEASES

JF - ANNALS OF THE RHEUMATIC DISEASES

T2 - Annual European Congress of Rheumatology (EULAR)

Y2 - 12 June 2019 through 15 June 2019

ER -

Guhring H, Kraines J, Moreau F, Daelken B, Ladel C, Wirth W et al. CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL. ANNALS OF THE RHEUMATIC DISEASES. 2019;78:70-71. doi: 10.1136/annrheumdis-2019-eular.1216